High Mobility Group AT-hook 2: A Biomarker Associated with Resistance to Enzalutamide in Prostate Cancer Cells
Yusuf Liadi(Umaru Musa Yar'adua University), Valerie Odero‐Marah(Morgan State University)
Cited by 2
Related Papers
Receptor activator of NF-κB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells
|Cell Research|2008|140
Proteomics-Metabolomics Combined Approach Identifies Peroxidasin as a Protector against Metabolic and Oxidative Stress in Prostate Cancer
|International Journal of Molecular Sciences|2019|52
HMGA2 regulates GPX4 expression and ferroptosis in prostate cancer cells
|Biochemical and Biophysical Research Communications|2024|6